Heart vibration test for cardiovascular risk
Part of Heart & circulation clinical trials.
This trial uses a special device that measures vibrations from your heart to see if it can better predict your risk for heart disease. It's for people already in the larger SCAPIS 2 study who had an echocardiography exam.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already part of the SCAPIS 2 study at Danderyd Hospital in Stockholm.
- You also had the echocardiography (ultrasound of your heart) exam.
- You can understand and agree to take part after the study is explained to you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new handheld device that uses gentle pulses to measure stiffness of your arteries, which can help predict heart disease risk. It is a quick, non-invasive test for people coming in for regular check-ups.
This trial studies data and samples from people already taking part in the main SCAPIS reexamination study in Stockholm. It looks for new findings to help understand heart and lung health.
This study checks if tiny blood vessel problems in the heart affect how well the heart muscle recovers after being weak. It uses special imaging during a routine heart catheterization to look at these small vessels.
This study tests a non-invasive CT scan method to detect blockages in the heart arteries in people with suspected stable coronary artery disease. The goal is to find a safe and accurate way to diagnose without invasive procedures.
This trial uses a noninvasive device to examine small blood vessels in people at high risk for heart disease. It may help doctors better understand who needs preventive care.
This study tests a new, painless device that uses sound waves to check for blocked heart arteries. It could help your doctor find out if you have coronary artery disease without more invasive tests.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.